Aurobindo Pharma Limited

NSE:AUROPHARMA.NS

1327.55 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Assets:
Current Assets:
Cash & Cash Equivalents 62,78343,962.941,625.153,734.727,637.118,554.311,948.14,878.58,329.54,678.61,785.82,076.7703.21,881.9728.31,276.52,825.75,824.62,019.3593.9622.6
Short Term Investments 505.821,292.63,951.32,477.3784.6735457.4240.60.2196.50.30.4186.80000.60.50.50.30.3
Cash and Short Term Investments 63,288.865,255.545,576.456,21228,421.719,289.312,405.55,119.18,329.74,875.11,786.12,077.18901,881.9728.31,276.52,826.35,825.12,019.8594.2622.9
Net Receivables 48,352.746,401.944,561.937,269.343,846.759,644.148,157.940,845.749,104.840,434.229,730.519,064.915,591.617,472.613,273.112,766.86,650.16,261.15,822.34,533.34,777.2
Inventory 98,082.385,112.375,538.590,265.776,998.772,45658,584.143,305.440,88136,11323,675.419,235.915,455.614,552.611,024.58,776.37,950.36,5444,718.13,754.63,193.8
Other Current Assets 32,332.518,68715,550.114,488.114,857.92,255.72,730.92,791.61,699.21,565.71,119.8989.6703.214.333.470.13,164.12,718.91,996.61,305996.3
Total Current Assets 242,056.3215,456.7181,226.9198,235.1164,125153,645.1121,878.492,061.8100,014.782,98856,311.841,367.532,640.433,921.425,059.322,889.720,590.821,349.114,556.810,187.19,590.2
Non-Current Assets:
Property, Plant & Equipment, Net 142,849124,917.8106,659.993,155.181,166.370,355.961,36153,204.143,925.532,721.528,06826,386.425,871.717,38621,687.218,370.514,164.212,750.211,491.910,571.68,670.4
Goodwill 5,951.55,960.74,754.24,2899,159.48,325.18,165.54,0634,490.45,333763.8554.4541.40480.7525.5531.6538.623500
Intangible Assets 34,814.633,258.531,378.726,90723,498.422,752.111,510.75,651.54,219.53,198.21,482.11,6331,987.50640.6454.7452.7424.4608536.5341.5
Goodwill and Intangible Assets 40,766.139,219.236,132.931,19632,657.831,077.219,676.29,714.58,709.98,531.22,245.92,187.42,528.901,121.3980.2984.3963843536.5341.5
Long Term Investments 6,784.83,917.36,182.94,312.15,546.82,8862,677.72,278.71.2-195.1197.322211.802.80603.72.22.32.12.1
Tax Assets 12,126.46,774.92,885.94,526.81,6321,832.91,5881,677.60.947.50.5054.343.541.721.71.2193.60.10.254.5
Other Non-Current Assets 6,132.58,6146,128.77,114.84,135.64,746.63,870.73,557.54,341.35,051.78,074.72,615.11,269.27,421.50.82.60.6-193.10.50.30.3
Total Non-Current Assets 208,658.8183,443.2157,990.3140,304.8125,138.5110,898.689,173.670,432.456,978.846,156.838,586.431,410.929,735.924,85122,853.819,37515,75413,715.912,337.811,110.79,068.8
Total Assets 450,715.1398,899.9339,217.2338,539.9289,263.5264,543.7211,052162,494.2156,993.5129,144.894,898.272,778.462,376.358,772.447,913.142,264.736,344.835,06526,894.621,297.818,659
Liabilities & Equity:
Current Liabilities:
Account Payables 44,541.638,713.127,030.527,946.825,450.126,771.326,274.424,882.725,267.720,511.213,5129,687.46,601.406,0445,147.74,631.74,205.13,861.32,902.82,251.7
Short Term Debt 42,60243,457.227,111.451,152.160,368.167,868.143,187.431,827.438,547.730,89624,897.822,87221,313.10136.8116103.666.357.60.10.4
Tax Payables 2,490.12,116580.32,103.61,282.4662.7431.1264.6820.1000000000000
Deferred Revenue 2,490.121,33526,138.526,436.426,90025,342.116,413.88,932.610,176.99,532.63,571.51,705.81,112.90710.3319.5350.5295.6210.2167.1256.1
Other Current Liabilities 32,357.611,432.51,279.41,116.21,149.3447.5930.6580.5766.5424.2219.193123.18,862.8188.8117.3783.2139.2136.2130149.1
Total Current Liabilities 121,991.3114,937.881,559.8106,651.5113,867.5120,42986,806.266,223.274,758.861,36442,200.434,358.229,150.58,862.87,079.95,700.55,8694,706.24,265.33,2002,657.3
Non-Current Liabilities:
Long Term Debt 21,3499,404.95,678.24,345.92,644.11,799.54,5121,8148,47213,614.712,793.611,482.69,646.324,143.521,545.623,329.718,470.220,781.413,730.710,340.38,230.7
Deferred Revenue Non-Current 2,525.317,295.81,831.42,112747.1465.40224.10000000000000
Deferred Tax Liabilities Non-Current 3,565.63,896.14,109.65,745.63,024.82,813.12,352.84932,364.52,105.32,054.268038.51,226.6953.5790.4733.4681.9725.6612.7521.1
Other Non-Current Liabilities 2,775.9-15,153.2297.7395874.8113558.69,808.6235.4243.591.89042.4000024.2000
Total Non-Current Liabilities 30,215.815,443.611,916.912,598.57,290.85,1917,423.412,339.711,071.915,963.514,939.612,252.69,727.225,370.122,499.124,120.119,203.621,487.514,456.310,9538,751.8
Total Liabilities 152,207.1130,381.493,476.7119,250121,158.3125,62094,229.678,562.985,830.777,327.557,14046,610.838,877.734,232.929,57929,820.625,072.626,193.718,721.614,15311,409.1
Equity:
Preferred Stock 000000000000000000000
Common Stock 585.9585.9585.9585.9585.9585.9585.9585.9585.2292291.5291.2291.1291.1278.6268.8268.8266.7266.3253.9253.9
Retained Earnings 268,014.2240,130.3225,190.1201,367.6150,585.5124,161.5102,117.672,424.155,979.637,918.523,920.414,386.612,452.8004,884.94,293.92,405.4783.600
Accumulated Other Comprehensive Income/Loss 25,64923,503.415,804.913,166.313,057.9-17,346.8-11,842.7-7,167.6-18,707-15,369.2-12,297.4-9,897.3-7,975.9-6,404.8-6,644.2-5,543.1-4,073.7-3,075-2,639.3-1,971.5-1,393.9
Other Total Stockholders Equity 4,178.94,178.94,178.94,178.93,874.531,507.225,943.418,068.132,709.528,717.825,58721,277.118,628.530,56224,656.412,80210,751.29,2639,738.18,8508,381.8
Total Shareholders Equity 298,428268,398.5245,759.8219,298.7168,103.8138,907.8116,804.283,910.570,567.351,559.137,501.526,057.623,396.524,448.318,290.812,412.611,240.28,860.18,148.77,132.47,241.8
Total Equity 298,508268,518.5245,740.5219,289.9168,105.2138,923.7116,822.483,931.371,162.851,817.337,758.226,167.623,498.624,539.518,334.112,444.111,272.28,895.58,1737,144.87,249.9
Total Liabilities & Shareholders Equity 450,715.1398,899.9339,217.2338,539.9289,263.5264,543.7211,052162,494.2156,993.5129,144.894,898.272,778.462,376.358,772.447,913.142,264.736,344.835,089.226,894.621,297.818,659